STAT3 and Hepatic fibrosis: In line with our finding that IF reduces hepatic LCN2, MMP9, and pSTAT3 expression in HFD-fed mice, LCN2 deletion and administration of a STAT3 phosphorylation inhibitor reduced inflammation and hepatic fibrosis [26].